{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T07:13:48Z","timestamp":1787987628989,"version":"build-2784847793"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.colsurfb.2019.04.028","type":"journal-article","created":{"date-parts":[[2019,4,14]],"date-time":"2019-04-14T09:46:28Z","timestamp":1555235188000},"page":"453-461","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Facile fabrication of PEG-coated PLGA microspheres via SPG membrane emulsification for the treatment of scleroderma by ECM degrading enzymes"],"prefix":"10.1016","volume":"179","author":[{"given":"Seiichi","family":"Ohta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Matsuura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Kawashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Machiko","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Okochi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihide","family":"Asano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taichi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.colsurfb.2019.04.028_bib0005","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1021\/cr940351u","article-title":"Polymeric systems for controlled drug release","volume":"99","author":"Uhrich","year":"1999","journal-title":"Chem. Rev."},{"key":"10.1016\/j.colsurfb.2019.04.028_bib0010","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijpharm.2006.10.036","article-title":"Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres","volume":"334","author":"Mao","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2019.04.028_bib0015","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3390\/polym3031377","article-title":"Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier","volume":"3","author":"Makadia","year":"2011","journal-title":"Polymers"},{"key":"10.1016\/j.colsurfb.2019.04.028_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0168-3659(91)90126-X","article-title":"Preparation of biodegradable microspheres and microcapsules: 2. Polyactides and related polyesters","volume":"17","author":"Arshady","year":"1991","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2019.04.028_bib0025","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1089\/ten.tea.2013.0403","article-title":"Hyaluronidase-loaded PLGA microparticles as a new strategy for the treatment of pulmonary fibrosis","volume":"21","author":"da Silva Bitencourt","year":"2015","journal-title":"Tissue Eng. Part A"},{"key":"10.1016\/j.colsurfb.2019.04.028_bib0030","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/jctb.969","article-title":"The membrane emulsification process - a review","volume":"79","author":"Charcosset","year":"2004","journal-title":"J. Chem. Technol. Biotechnol."},{"key":"10.1016\/j.colsurfb.2019.04.028_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.colsurfb.2015.01.018","article-title":"Preparation of uniform-sized hemoglobin-albumin microspheres as oxygen carriers by Shirasu porous glass membrane emulsification technique","volume":"127","author":"Lai","year":"2015","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.colsurfb.2019.04.028_bib0040","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1252\/jcej.13we100","article-title":"Preparation of uniform-sized poly[methacryloxypropyl tris(trimethylsiloxy)silane] microspheres via shirasu porous glass membrane emulsification technique","volume":"46","author":"Lai","year":"2013","journal-title":"J. Chem. Eng. Jpn."},{"key":"10.1016\/j.colsurfb.2019.04.028_bib0045","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jcis.2011.12.078","article-title":"Size-controlled and monodisperse enzyme-encapsulated chitosan microspheres developed by the SPG membrane emulsification technique","volume":"371","author":"Akamatsu","year":"2012","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.colsurfb.2019.04.028_bib0050","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.colsurfb.2008.07.008","article-title":"Preparation and properties of PLGA microspheres containing hydrophilic drugs by the SPG (shirasu porous glass) membrane emulsification technique","volume":"67","author":"Ito","year":"2008","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.colsurfb.2019.04.028_bib0055","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.colsurfb.2004.08.016","article-title":"Preparation and properties of monodispersed rifampicin-loaded poly(lactide-co-glycolide) microspheres","volume":"39","author":"Ito","year":"2004","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.colsurfb.2019.04.028_bib0060","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1021\/mp8001254","article-title":"Controlled surface modification with poly(ethylene)glycol enhances diffusion of PLGA nanoparticles in human cervical mucus","volume":"6","author":"Cu","year":"2009","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.colsurfb.2019.04.028_bib0065","doi-asserted-by":"crossref","first-page":"6791","DOI":"10.1016\/j.biomaterials.2011.04.082","article-title":"The influence of PEG chain length and targeting moiety on antibody-mediated delivery of nanoparticle vaccines to human dendritic cells","volume":"32","author":"Cruz","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.colsurfb.2019.04.028_bib0070","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1023\/A:1022366921298","article-title":"Ligand-specific targeting of microspheres to phagocytes by surface modification with poly(L-lysine)-grafted poly(ethylene glycol) conjugate","volume":"20","author":"Faraasen","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/j.colsurfb.2019.04.028_bib0075","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.biomaterials.2006.09.047","article-title":"Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery","volume":"28","author":"Cheng","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/j.colsurfb.2019.04.028_bib0080","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0927-7765(99)00156-3","article-title":"\u2019STealth\u2019 corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption","volume":"18","author":"Gref","year":"2000","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.colsurfb.2019.04.028_bib0085","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1172\/JCI31139","article-title":"Systemic sclerosis: a prototypic multisystem fibrotic disorder","volume":"117","author":"Varga","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.colsurfb.2019.04.028_bib0090","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1056\/NEJMra0806188","article-title":"Scleroderma","volume":"360","author":"Gabrielli","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.colsurfb.2019.04.028_bib0095","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.semarthrit.2007.05.003","article-title":"Incidence and prevalence of systemic sclerosis: a systematic literature review","volume":"37","author":"Chifflot","year":"2008","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.colsurfb.2019.04.028_bib0100","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/nature12614","article-title":"Integrin-modulating therapy prevents fibrosis and autoimmunity in mouse models of scleroderma","volume":"503","author":"Gerber","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.colsurfb.2019.04.028_bib0105","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aal3765","article-title":"Targeted apoptosis of myofibroblasts with the BH3 mimetic ABT-263 reverses established fibrosis","volume":"9","author":"Lagares","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.colsurfb.2019.04.028_bib0110","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1159\/000366405","article-title":"Anti-fibrotic effects of Astragaloside IV in systemic sclerosis","volume":"34","author":"Qi","year":"2014","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.colsurfb.2019.04.028_bib0115","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.3892\/ijmm.2012.1150","article-title":"Ciprofloxacin has antifibrotic effects in scleroderma fibroblasts via downregulation of Dnmt1 and upregulation of Fli1","volume":"30","author":"Bujor","year":"2012","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.colsurfb.2019.04.028_bib0120","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1002\/art.24380","article-title":"C. the Scleroderma Clinical Trials, Recombinant human relaxin in the treatment of systemic sclerosis with diffuse cutaneous involvement: a randomized, double-blind, placebo-controlled trial","volume":"60","author":"Khanna","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.colsurfb.2019.04.028_bib0125","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1755-1536-3-8","article-title":"Towards an anti-fibrotic therapy for scleroderma: targeting myofibroblast differentiation and recruitment","volume":"3","author":"Leask","year":"2010","journal-title":"Fibrogenesis Tissue Repair"},{"key":"10.1016\/j.colsurfb.2019.04.028_bib0130","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.jhsa.2010.01.003","article-title":"Collagenase injection as nonsurgical treatment of Dupuytren\u2019s disease: 8-year follow-up","volume":"35","author":"Watt","year":"2010","journal-title":"J. Hand Surg."},{"key":"10.1016\/j.colsurfb.2019.04.028_bib0135","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1056\/NEJMoa0810866","article-title":"Injectable collagenase clostridium histolyticum for Dupuytren\u2019s contracture","volume":"361","author":"Hurst","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.colsurfb.2019.04.028_bib0140","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1517\/14712590903490382","article-title":"Hyaluronidase: a review of approved formulations, indications and off-label use in chronic pain management","volume":"10","author":"Dunn","year":"2010","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.colsurfb.2019.04.028_bib0145","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0304-3835(98)00195-5","article-title":"Hyaluronidase and its substrate hyaluronan: biochemistry, biological activities and therapeutic uses","volume":"131","author":"Menzel","year":"1998","journal-title":"Cancer Lett."},{"key":"10.1016\/j.colsurfb.2019.04.028_bib0150","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/j.1524-4725.2010.01585.x","article-title":"Hyaluronidase","volume":"36","author":"Lee","year":"2010","journal-title":"Dermatol. Surg."},{"key":"10.1016\/j.colsurfb.2019.04.028_bib0155","doi-asserted-by":"crossref","first-page":"7782","DOI":"10.1158\/0008-5472.CAN-05-1022","article-title":"HYAL1 hyaluronidase in prostate cancer: a tumor promoter and suppressor","volume":"65","author":"Lokeshwar","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.colsurfb.2019.04.028_bib0160","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.semcancer.2008.03.017","article-title":"Hyaluronidases in cancer biology","volume":"18","author":"Stern","year":"2008","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.colsurfb.2019.04.028_bib0165","article-title":"High response rate and PFS with PEGPH20 added to nab-paclitaxel\/gemcitabine in stage IV previously untreated pancreatic cancer patients with high-HA tumors: interim results of a randomized phase II study","volume":"33","author":"Hingorani","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.colsurfb.2019.04.028_bib0170","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1517\/14712590903490382","article-title":"Hyaluronidase: a review of approved formulations, indications and off-label use in chronic pain\u2009management","volume":"10","author":"Dunn","year":"2010","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.colsurfb.2019.04.028_bib0175","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1053\/jhsu.2002.35299","article-title":"Collagen as a clinical target: nonoperative treatment of Dupuytren\u2019s disease","volume":"27","author":"Badalamente","year":"2002","journal-title":"J. Hand Surg. Am."},{"key":"10.1016\/j.colsurfb.2019.04.028_bib0180","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.2353\/ajpath.2008.071049","article-title":"CD19 regulates skin and lung fibrosis via Toll-like receptor signaling in a model of bleomycin-induced scleroderma","volume":"172","author":"Yoshizaki","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.colsurfb.2019.04.028_bib0185","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/art.38948","article-title":"Fibrosis, vascular activation, and immune abnormalities resembling systemic sclerosis in bleomycin-treated Fli-1-haploinsufficient mice","volume":"67","author":"Taniguchi","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.colsurfb.2019.04.028_bib0190","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/0142-9612(88)90033-6","article-title":"Effect of the size and surface charge of polymer microspheres on their phagocytosis by macrophage","volume":"9","author":"Tabata","year":"1988","journal-title":"Biomaterials"},{"key":"10.1016\/j.colsurfb.2019.04.028_bib0195","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1002\/btpr.2170","article-title":"Size-dependent interaction of cells and hemoglobin-albumin based oxygen carriers prepared using the SPG membrane emulsification technique","volume":"31","author":"Lai","year":"2015","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.colsurfb.2019.04.028_bib0200","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1007\/s11095-012-0720-x","article-title":"Protein encapsulation in unilamellar liposomes: high encapsulation efficiency and a novel technique to assess lipid-protein interaction","volume":"29","author":"Xu","year":"2012","journal-title":"Pharm. Res."},{"key":"10.1016\/j.colsurfb.2019.04.028_bib0205","doi-asserted-by":"crossref","first-page":"5797","DOI":"10.1038\/ncomms6797","article-title":"Simultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosis","volume":"5","author":"Noda","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.colsurfb.2019.04.028_bib0210","doi-asserted-by":"crossref","DOI":"10.1186\/ar4230","article-title":"Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells","volume":"15","author":"Gilbane","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.colsurfb.2019.04.028_bib0215","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0169-409X(97)00048-3","article-title":"Biodegradation and biocompatibility of PLA and PLGA microspheres","volume":"28","author":"Shive","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.colsurfb.2019.04.028_bib0220","doi-asserted-by":"crossref","first-page":"6692","DOI":"10.1016\/j.biomaterials.2011.05.078","article-title":"Immune responses to implants - a review of the implications for the design of immunomodulatory biomaterials","volume":"32","author":"Franz","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.colsurfb.2019.04.028_bib0225","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1016\/S0142-9612(02)00053-4","article-title":"Effect of tricaprin on the physical characteristics and in vitro release of etoposide from PLGA microspheres","volume":"23","author":"Schaefer","year":"2002","journal-title":"Biomaterials"},{"key":"10.1016\/j.colsurfb.2019.04.028_bib0230","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ijpharm.2005.12.016","article-title":"PLGA microcapsules with novel dimpled surfaces for pulmonary delivery of DNA","volume":"311","author":"Mohamed","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2019.04.028_bib0235","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1023\/A:1018912426983","article-title":"Polylactide microparticles prepared by double emulsion\/evaporation technique. I. Effect of primary emulsion stability","volume":"11","author":"Nihant","year":"1994","journal-title":"Pharm. Res."},{"key":"10.1016\/j.colsurfb.2019.04.028_bib0240","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0142-9612(00)00178-2","article-title":"Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction\/evaporation method","volume":"22","author":"Yang","year":"2001","journal-title":"Biomaterials"},{"key":"10.1016\/j.colsurfb.2019.04.028_bib0245","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1006\/jsre.1993.1004","article-title":"Correlation of high-speed tensile strength with collagen content in control and lathyritic rat skin","volume":"54","author":"Dombi","year":"1993","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.colsurfb.2019.04.028_bib0250","first-page":"611","article-title":"The roles of hyaluronic acid, collagen and elastin in the mechanical properties of connective tissues","volume":"131","author":"Oxlund","year":"1980","journal-title":"J. Anat."},{"key":"10.1016\/j.colsurfb.2019.04.028_bib0255","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.2277","article-title":"Cellular and molecular mechanisms of fibrosis","volume":"214","author":"Wynn","year":"2008","journal-title":"J. Pathol."},{"key":"10.1016\/j.colsurfb.2019.04.028_bib0260","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.1074\/jbc.M310999200","article-title":"Essential role of matrix metalloproteinases in interleukin-1-induced myofibroblastic activation of hepatic stellate cell in collagen","volume":"279","author":"Han","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.colsurfb.2019.04.028_bib0265","first-page":"301","article-title":"Fibroblasts and myofibroblasts in wound healing","volume":"7","author":"Darby","year":"2014","journal-title":"Clin. Cosmet. Investig. Dermatol."}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776519302516?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776519302516?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T10:38:30Z","timestamp":1760524710000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0927776519302516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":53,"alternative-id":["S0927776519302516"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2019.04.028","relation":{},"ISSN":["0927-7765"],"issn-type":[{"value":"0927-7765","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Facile fabrication of PEG-coated PLGA microspheres via SPG membrane emulsification for the treatment of scleroderma by ECM degrading enzymes","name":"articletitle","label":"Article Title"},{"value":"Colloids and Surfaces B: Biointerfaces","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.colsurfb.2019.04.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}